» Articles » PMID: 15489344

Mycoplasma Pneumoniae and Its Role As a Human Pathogen

Overview
Specialty Microbiology
Date 2004 Oct 19
PMID 15489344
Citations 518
Authors
Affiliations
Soon will be listed here.
Abstract

Mycoplasma pneumoniae is a unique bacterium that does not always receive the attention it merits considering the number of illnesses it causes and the degree of morbidity associated with it in both children and adults. Serious infections requiring hospitalization, while rare, occur in both adults and children and may involve multiple organ systems. The severity of disease appears to be related to the degree to which the host immune response reacts to the infection. Extrapulmonary complications involving all of the major organ systems can occur in association with M. pneumoniae infection as a result of direct invasion and/or autoimmune response. The extrapulmonary manifestations are sometimes of greater severity and clinical importance than the primary respiratory infection. Evidence for this organism's contributory role in chronic lung conditions such as asthma is accumulating. Effective management of M. pneumoniae infections can usually be achieved with macrolides, tetracyclines, or fluoroquinolones. As more is learned about the pathogenesis and immune response elicited by M. pneumoniae, improvement in methods for diagnosis and prevention of disease due to this organism may occur.

Citing Articles

Atypical pathogen community-acquired pneumonia: an analysis of clinical characteristics, drug treatment, and prognosis in the related patients.

Yu Y, Li M Mol Biol Rep. 2025; 52(1):309.

PMID: 40085176 DOI: 10.1007/s11033-025-10382-w.


Bacterial Amino Acid Auxotrophies Enable Energetically Costlier Proteomes.

Kasalo N, Domazet-Loso T, Domazet-Loso M Int J Mol Sci. 2025; 26(5).

PMID: 40076905 PMC: 11900164. DOI: 10.3390/ijms26052285.


Mycoplasma pneumoniae MLST detected in the upsurge of pneumonia during the 2023 to 2024 winter season in the Netherlands.

Smit P, Eggink D, Paltansing S, Hooiveld M, van Gageldonk-Lafeber A, Dunk D Sci Rep. 2025; 15(1):6985.

PMID: 40011487 PMC: 11865550. DOI: 10.1038/s41598-025-88990-6.


Rapid and facile detection of Mycoplasma pneumoniae 16S rRNA based on CHA-FICA system.

Cai S, Yao Y, Chen Y, Abudushalamua G, Ma S, Wang J Mikrochim Acta. 2025; 192(2):128.

PMID: 39893283 DOI: 10.1007/s00604-025-06971-y.


Characteristics of the 2023-2024 epidemic in adults, Southeast France.

Wolski A, Edouard S, Melo B, Lavrard P, Cortaredona S, Punturo J IJID Reg. 2025; 14:100548.

PMID: 39877414 PMC: 11773249. DOI: 10.1016/j.ijregi.2024.100548.


References
1.
Chanock R, Rifkind D, KRAVETZ H, KINGHT V, Johnson K . Respiratory disease in volunteers infected with Eaton agent: a preliminary report. Proc Natl Acad Sci U S A. 1961; 47:887-90. PMC: 221357. DOI: 10.1073/pnas.47.6.887. View

2.
Ito S, Abe Y, Kinomoto K, Saitoh T, Kato T, Kohli Y . Fulminant Mycoplasma pneumoniae pneumonia with marked elevation of serum soluble interleukin-2 receptor. Intern Med. 1995; 34(5):430-5. DOI: 10.2169/internalmedicine.34.430. View

3.
Chester A, Kane J, Garagusi V . Mycoplasma pneumonia with bilateral pleural effusions. Am Rev Respir Dis. 1975; 112(3):451-6. DOI: 10.1164/arrd.1975.112.3.451. View

4.
Dionisio D, Valassina M, Mata S, Rossetti R, VIVARELLI A, Esperti F . Encephalitis caused directly by Mycoplasma pneumoniae. Scand J Infect Dis. 1999; 31(5):506-9. DOI: 10.1080/00365549950164067. View

5.
Lucier T, Heitzman K, Liu S, Hu P . Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1995; 39(12):2770-3. PMC: 163027. DOI: 10.1128/AAC.39.12.2770. View